Revenue · 2011–2025
Supernus Pharmaceuticals revenue
$719M+8.6% · FY2025
Supernus Pharmaceuticals (SUPN) reported $719M in revenue for fiscal 2025, +8.6% year on year.
| Fiscal year | Revenue | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | $719M | +8.6% | Open → |
| FY20242024-12-31 | $662M | +8.9% | Open → |
| FY20232023-12-31 | $608M | −8.9% | Open → |
| FY20222022-12-31 | $667M | +15.1% | Open → |
| FY20212021-12-31 | $580M | +11.4% | Open → |
| FY20202020-12-31 | $520M | +32.5% | Open → |
| FY20192019-12-31 | $393M | −3.9% | Open → |
| FY20182018-12-31 | $409M | +35.3% | Open → |
| FY20172017-12-31 | $302M | +40.6% | Open → |
| FY20162016-12-31 | $215M | +45.8% | Open → |
| FY20152015-12-31 | $147M | +59.1% | Open → |
| FY20142014-12-31 | $92.7M | +671.1% | Open → |
| FY20132013-12-31 | $12.0M | +712.1% | Open → |
| FY20122012-12-31 | $1.5M | +84.3% | Open → |
| FY20112011-12-31 | $803,000 | — | Open → |
Revenue — Revenue is total net sales for the fiscal year, taken from each company's own annual filing.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2011–2025 compound annual growth +62.5%
Revenue at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Supernus Pharmaceuticals revenue |url=https://companiesranked.com/en/company/supernus-pharmaceuticals/revenue |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Supernus Pharmaceuticals revenue. CompaniesRanked. https://companiesranked.com/en/company/supernus-pharmaceuticals/revenueBibTeX
@misc{companiesranked-en-company-supernus-pharmaceuticals-revenue-2026,
author = {{CompaniesRanked}},
title = {{Supernus Pharmaceuticals revenue}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/supernus-pharmaceuticals/revenue}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-K · 0001356576-26-000011 · March 2, 2026
{{cite web |title=Supernus Pharmaceuticals revenue — 10-K (0001356576-26-000011) |url=https://www.sec.gov/Archives/edgar/data/1356576/000135657626000011/supn-20251231.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-03-02}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.